Evolution of Innate and Adaptive Effector Cell Functions during Acute HIV‐1 Infection
Partners AIDS Research Center, Infectious Disease Unit, Massachusetts General Hospital, and Division of AIDS, Harvard Medical School, Boston
Early events during acute human immunodeficiency virus type 1 (HIV‐1) infection are critical in determining the course of disease progression. Cells of the innate and adaptive immune responses are involved in this acute response to infection; however, little is known about the coevolution of innate and adaptive effector cell populations during the initial phase of HIV‐1 infection. Here, we have characterized the development of innate natural killer (NK) cell and adaptive HIV‐1–specific CD8+ T cell function during acute HIV‐1 infection. Although NK cell populations were significantly expanded during acute infection before HIV‐1 seroconversion, HIV‐1–specific CD8+ T cell responses were absent or weak and were inversely correlated with the level of NK cell activity. NK cell activity was directly correlated with the level of viral replication during acute HIV‐1 infection and declined rapidly in subjects who initiated highly active antiretroviral therapy, whereas NK cell activity remained elevated in subjects who did not initiate therapy. Yet, reexposure to HIV‐1 antigen during treatment discontinuation in chronic infection resulted in a synchronous increase in NK and CD8+ T cell activity. Overall, these data demonstrate that expansion of the NK cell population precedes the development of adaptive HIV‐1–specific CD8+ T cells during acute infection but that both effector cell subsets respond with similar kinetics during chronic HIV‐1 infection.
Received 13 October 2006; accepted 7 December 2006; electronically published 10 April 2007.
Cited by
Online publication date: 1-Jan-2009.
CrossRef
Online publication date: 1-Jan-2009.
CrossRef
Online publication date: 1-Mar-2008.
CrossRef
Online publication date: 1-Feb-2008.
CrossRef
Online publication date: 1-Feb-2008.
CrossRef
-
Potential conflicts of interest: none reported.
Financial support: National Institutes of Health (grant 5R01AI67031); Harvard University Center for AIDS Research (grant 1 P30 AI060354‐01).





